Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Renal denervation for resistant hypertension.

Literature DB >> 25006731

Renal denervation for resistant hypertension.

Deepak L Bhatt, George L Bakris.

Abstract

Entities: Disease

Mesh：

Year: 2014 PMID： 25006731 DOI： 10.1056/NEJMc1405677

Source DB: PubMed Journal: N Engl J Med ISSN： 0028-4793 Impact factor: 91.245

Keyword Cloud
Cited

× No keyword cloud information.

12 in total

1. Neuropeptide Y as an indicator of successful alterations in sympathetic nervous activity after renal sympathetic denervation.

Authors: Oliver Dörr; Sebastian Ewen; Christoph Liebetrau; Helge Möllmann; Luise Gaede; Dominik Linz; Mathias Hohl; Christian Troidl; Timm Bauer; Michael Böhm; Christian Hamm; Felix Mahfoud; Holger Nef
Journal: Clin Res Cardiol Date: 2015-05-26 Impact factor: 5.460

2. Renal denervation--a valid treatment option despite SYMPLICITY HTN-3.

Authors: Roland E Schmieder
Journal: Nat Rev Cardiol Date: 2014-09-30 Impact factor: 32.419

3. Impact of renal denervation on tissue Na⁺ content in treatment-resistant hypertension.

Authors: Christian Ott; Christoph Kopp; Anke Dahlmann; Axel Schmid; Peter Linz; Alexander Cavallaro; Matthias Hammon; Tilmann Ditting; Roland Veelken; Michael Uder; Jens Titze; Roland E Schmieder
Journal: Clin Res Cardiol Date: 2017-08-28 Impact factor: 5.460

Review 4. Renal Denervation for Resistant Hypertension: Past, Present, and Future.

Authors: Christian Ott; Roland E Schmieder
Journal: Curr Hypertens Rep Date: 2015-08 Impact factor: 5.369

Review 5. Sodium-Glucose Cotransporter 2 Inhibitors in Patients with Non-Diabetic Chronic Kidney Disease.

Authors: Akira Mima
Journal: Adv Ther Date: 2021-04-16 Impact factor: 3.845

6. Identifying and treating resistant hypertension in PRECISION: A randomized long-term clinical trial with aprocitentan.

Authors: Parisa Danaietash; Pierre Verweij; Ji-Guang Wang; George Dresser; Ilkka Kantola; Mary Katherine Lawrence; Krzysztof Narkiewicz; Markus Schlaich; Marc Bellet
Journal: J Clin Hypertens (Greenwich) Date: 2022-06-09 Impact factor: 2.885

Renal denervation for resistant hypertension.

1. Neuropeptide Y as an indicator of successful alterations in sympathetic nervous activity after renal sympathetic denervation.

2. Renal denervation--a valid treatment option despite SYMPLICITY HTN-3.

3. Impact of renal denervation on tissue Na⁺ content in treatment-resistant hypertension.

Review 4. Renal Denervation for Resistant Hypertension: Past, Present, and Future.

Review 5. Sodium-Glucose Cotransporter 2 Inhibitors in Patients with Non-Diabetic Chronic Kidney Disease.

6. Identifying and treating resistant hypertension in PRECISION: A randomized long-term clinical trial with aprocitentan.

7. Distal renal artery stenosis after percutaneous renal denervation leading to renal impairment but normotension.

Review 8. Device-based approaches for renal nerve ablation for hypertension and beyond.

Review 9. The renal nerves in chronic heart failure: efferent and afferent mechanisms.

10. The Creation of Surrogate Models for Fast Estimation of Complex Model Outcomes.

Renal denervation for resistant hypertension.

1. Neuropeptide Y as an indicator of successful alterations in sympathetic nervous activity after renal sympathetic denervation.

2. Renal denervation--a valid treatment option despite SYMPLICITY HTN-3.

3. Impact of renal denervation on tissue Na+ content in treatment-resistant hypertension.

Review 4. Renal Denervation for Resistant Hypertension: Past, Present, and Future.

Review 5. Sodium-Glucose Cotransporter 2 Inhibitors in Patients with Non-Diabetic Chronic Kidney Disease.

6. Identifying and treating resistant hypertension in PRECISION: A randomized long-term clinical trial with aprocitentan.

7. Distal renal artery stenosis after percutaneous renal denervation leading to renal impairment but normotension.

Review 8. Device-based approaches for renal nerve ablation for hypertension and beyond.

Review 9. The renal nerves in chronic heart failure: efferent and afferent mechanisms.

10. The Creation of Surrogate Models for Fast Estimation of Complex Model Outcomes.

3. Impact of renal denervation on tissue Na⁺ content in treatment-resistant hypertension.